Elizabeth Guidi > Dechert LLP > New York, United States > Lawyer Profile
Dechert LLP Offices
![Dechert LLP company logo](https://www.legal500.com/wp-content/uploads/sites/13/2022/05/9038.jpg?v=1653297619)
Three Bryant Park, 1095 Avenue of the Americas
NEW YORK, NY 10036-6797
NEW YORK
United States
- Firm Profile
- Go to...
Elizabeth Guidi
![Elizabeth Guidi photo](https://www.legal500.com/wp-content/uploads/sites/13/2023/06/elizabeth-guidi-portrait-240x300.jpg)
Work Department
Tax
Position
Partner
Career
Elizabeth A. Guidi focuses her practice on the U.S. tax aspects of transactions, including mergers and acquisitions and private equity fund formation. Ms. Guidi has significant experience representing public and private companies in matters relating to mergers and acquisitions and capital markets. She regularly represents clients across a variety of sectors and across a range of jurisdictions.
Education
- University of Notre Dame, B.A., 1999, Pi Alpha Theta, Notre Dame Scholar
- New York University, M.A., Humanities, 2004
- Queens College, The City University of New York, M.S., Secondary Education and Social Studies, 2005, New York City Teaching Fellow
- Brooklyn Law School, J.D., 2013, Brooklyn Law Review, Executive Board; Class of 1968 Evening Division Scholarship; John J. Meehan Scholarship; Herman Fagen Scholarship; Henrietta and Stuart Hirschman Memorial Prize; Professor Roberta S. Karmel Prize
Top Tier Firm Rankings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Antitrust > Civil litigation/class actions: defense
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
- Finance > Structured finance: securitization
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- International trade > Customs, export controls and economic sanctions
- Dispute resolution > International arbitration
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Financial services litigation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Investment fund formation and management > Alternative/hedge funds